Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

BABACAN, TANER; Buyukhatipoglu, Hakan; Balakan, Ozan; KERTMEN, NEYRAN; Suner, Ali; Sarici, Furkan; AKIN, SERKAN; ATEŞ, ÖZTÜRK; Karakas, Yusuf; Aslan, Alma; DIKER, OMER; Altundag, Kadri

Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

Copy For Citation

BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., ...More

JOURNAL OF BUON, vol.20, no.2, pp.479-486, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 20 Issue: 2
Publication Date: 2015
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.479-486
Hacettepe University Affiliated: Yes

Abstract

Introduction: In lymph node-negative, hormone-positive, and Her2-negative breast cancer patients, the benefits of adding adjuvant chemotherapy to hormonal therapy continue to be debated, especially for low to intermediate grade and small tumors.